These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3740976)

  • 1. [Therapeutic effect of pyridoxine and succinimide in the treatment of a patient with primary hyperoxaluria].
    Jerez E; Rapado A
    Arch Esp Urol; 1986 May; 39(4):279-82. PubMed ID: 3740976
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypooxaluric treatment with succinimide in renal oxalic lithiasis in man].
    Thomas J; Melon JM; Steg A; Aboulker P
    Therapie; 1971; 26(5):999-1005. PubMed ID: 5160352
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preventive treatment of oxalic lithiasis with an hypo-oxaluric: agent succinimide].
    Thomas J; Melon JM; Steg A; Aboulker P
    J Urol Nephrol (Paris); 1971 Dec; 77():Suppl:534-40. PubMed ID: 5155480
    [No Abstract]   [Full Text] [Related]  

  • 5. [Succinate (and succinimide), malate, oxaloacetate. Their therapeutic effects and mechanism of action of oxalic lithiasis].
    Thomas J; Thomas E; Duburque MT; Champagnac A; Melon JM; Desgrez P
    J Urol Nephrol (Paris); 1974 Sep; 80(9):789-92. PubMed ID: 4463256
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on some possible biochemical treatments of primary hyperoxaluria.
    Watts RW; Chalmers RA; Gibbs DA; Lawson AM; Purkiss P; Spellacy E
    Q J Med; 1979 Apr; 48(190):259-72. PubMed ID: 116301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoxine therapy of adult primary oxalosis.
    Will EJ; Bijvoet OL
    Proc Eur Dial Transplant Assoc; 1979; 16():727-8. PubMed ID: 549023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oxalic renal lithiasis, a metabolic disease?].
    Melon JM; Thomas J
    Agressologie; 1973; 14(6):357-65. PubMed ID: 4605835
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxine treatment of type 1 hyperoxaluria.
    Alinei P; Guignard JP; Jaeger P
    N Engl J Med; 1984 Sep; 311(12):798-9. PubMed ID: 6472373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of renal lithogenesis. (VIII) Therapeutic response of hyperoxaluric patients after 5 years' treatment].
    Ruiz-Marcellán FJ; Bernshtam J; Pinto B
    Rev Clin Esp; 1983 Jan; 168(1):9-12. PubMed ID: 6844687
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER; Cohanim M
    N Engl J Med; 1985 Apr; 312(15):953-7. PubMed ID: 3974685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxaluria, nonfamilial hyperoxaluric form of oxalic lithiasis].
    Desgrez P; Thomas J; David-Issartel R
    J Urol Nephrol (Paris); 1968 Sep; 74(9):685-9. PubMed ID: 5718185
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary hyperoxaluria: therapeutic strategies for the 90's.
    Scheinman JI
    Kidney Int; 1991 Sep; 40(3):389-99. PubMed ID: 1787639
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction of elevated plasma oxalic acid by pyridoxine therapy in patients on RDT.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H
    Proc Eur Dial Transplant Assoc; 1983; 19():308-12. PubMed ID: 6878246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of lithogenesis. VIII. Effect of DEAE-cellulose in absorptive hyperoxaluria].
    Pinto B; Bernshtam J
    Rev Clin Esp; 1978 Jan; 148(1):65-8. PubMed ID: 635255
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ; Hesse A; Berg W; Kirsten J; Nickel H
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.
    Mitwalli A; Ayiomamitis A; Grass L; Oreopoulos DG
    Int Urol Nephrol; 1988; 20(4):353-9. PubMed ID: 3170105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current trends in phosphotherapy. IV. Treatment of oxalic lithiasis].
    Eisinger J; d' Omezon Y; Recordier AM
    Mars Med; 1971; 108(9):605-8. PubMed ID: 5120435
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a 5-year treatment program in patients with hyperoxaluric stones.
    Pinto B; Ruiz-Marcellán FJ; Bernshtam J
    J Urol; 1983 Nov; 130(5):943-5. PubMed ID: 6632105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.